Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

DelveInsight’s, “Nonalcoholic Steatohepatitis Pipeline Insight” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Nonalcoholic Steatohepatitis pipeline ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

The findings are particularly relevant as the T1D market continues to evolve. (Image Credits: Pexel) A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro ...

A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and tirzepatide leads to significant reductions in HbA1c levels and body weight ...

FDA acted within its discretion in declaring end to shortage Compounders must stop making their versions of Zepbound Drug compounders making copycat versions of Eli Lilly & Co. ’s weight loss drug ...

T1D is an autoimmune disease characterised by the destruction of insulin-producing beta cells. Credit: Eviart via Shutterstock. A recent study published in Diabetes Technology & Therapeutics has ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture knockoff versions of Eli Lilly's tirzepatide while a lawsuit plays out.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly has reduced the prices of certain ...